Histamine H3 Receptor as a Drug Discovery Target | Journal of Medicinal Chemistry
IJERPH | Free Full-Text | Adult-Attention Deficit Hyperactive Disorder Symptoms Seem Not to Influence the Outcome of an Enhanced Agonist Opioid Treatment: A 30-Year Follow-Up
Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder | SpringerLink
Atomoxetine - Wikiwand
Warning: Atomoxetine may increase suicidal feelings by activating the Kappa Opioid receptor : r/ADHD
Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder | SpringerLink
Atomoxetine and circadian gene expression in human dermal fibroblasts from study participants with a diagnosis of attention-deficit hyperactivity disorder | SpringerLink
Mixed Kappa/Mu Partial Opioid Agonists as Potential Treatments for Cocaine Dependence - ScienceDirect
Full article: Preclinical evidence of new opioid modulators for the treatment of addiction
Prescription Drug Abuse - ppt download
Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review | SpringerLink
A review of the abuse potential assessment of atomoxetine: a nonstimulant medication for attention-deficit/hyperactivity disorder - Document - Gale OneFile: Health and Medicine
Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review | SpringerLink
ATOMOXETINE HYDROCHLORIDE
US10316021B2 - Heteroarylphenoxy benzamide kappa opioid ligands - Google Patents
A Narrative Pharmacological Review of Buprenorphine: A Unique Opioid for the Treatment of Chronic Pain | SpringerLink
Pathophysiological mechanisms and therapeutic approaches in obstructive sleep apnea syndrome | Signal Transduction and Targeted Therapy
Atomoksetin i behandling av AD/HD | Tidsskrift for Den norske legeforening
Kappa Agonists - an overview | ScienceDirect Topics
